Lv1
20 积分 2025-02-11 加入
73P: Real-world post-progression analysis of first-line osimertinib for EGFR-mutated advanced NSCLC in China (FLOURISH study)
8天前
已完结
Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial
15天前
已完结
[Chinese expert consensus on the diagnosis and treatment of acute graft-versus-host disease after hematopoietic stem cell transplantation (2024)]
24天前
已完结
Intra-articular injection of autologous adipose-derived stromal vascular fractions for knee osteoarthritis: a double-blind randomized self-controlled trial
1个月前
已完结
A practical MRI grading system for osteoarthritis of the knee: Association with Kellgren–Lawrence radiographic scores
1个月前
已完结
Abstract CT032: A phase 1/2, open-label, multicenter, dose escalation and efficacy study of mRNA-2416, a lipid nanoparticle encapsulated mRNA encoding human OX40L, for intratumoral injection alone or in combination with durvalumab for patients with advanced malignancies
1个月前
已关闭
Intratumoral immunotherapy: using the tumor as the remedy
1个月前
已完结
Durable anticancer immunity from intratumoral administration of IL-23, IL-36γ, and OX40L mRNAs
1个月前
已完结
皖公网安备34019202002308
